A Biologically Effective Dose of ≥105 Gy Is Associated With Improved Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
Stahl, J.M., Ross, R., Harder, E.M., Mancini, B.R., Soulos, P.R., Dosoretz, A.P., Finkelstein, S.E., Shafman, T.D., Husain, Z.A., Evans, S.B., Yu, J.B., Gross, C.P., Decker, R.H.Volume:
96
Language:
english
Journal:
International Journal of Radiation Oncology*Biology*Physics
DOI:
10.1016/j.ijrobp.2016.06.438
Date:
October, 2016
File:
PDF, 77 KB
english, 2016